##common.pageHeaderLogo.altText##

Vol. 4 No. 6 (2024)

Studies of Lipid Profiles Among Infants with Respiratory Distress Syndrome

Clinical Medicine And Health Research Journal, Vol. 4 No. 6 (2024), 1 November 2024 , Page 1024-1030
https://doi.org/10.18535/cmhrj.v4i6.409

Abstract

Background: Respiratory distress syndrome (RDS) is known as hyaline membrane disease (HMD). It is the major cause of neonatal respiratory distress, especially in preterm infants Infants with RDS present with tachapnea, cyanosis, grunting, subcostal and intercostal retractions and nasal flaring. Oliguria with mild generalized edema may be present. Oxygen requirement may increase rapidly and is typically higher than that seen in infant with transient tachapnea of the newborn (TTN).


Objective: to evaluate the relationship between the maternal and cord blood lipid profiles in preterm babies with respiratory distress syndrome.


Methods: This is a case control study which was conducted on 50 preterm neonates admitted to the neonatal intensive care unit of Shebin El-Kom teaching hospital between January 2020 and October 2021.


Results: the mean of total cholesterol was significantly higher in infants whose mothers had received antenatal steroid for lung maturity than those whose mothers had not (P<0.05). But there was no significant difference in the mean of levels of TG, HDL-cholesterol, LDL-cholesterol and VLDL cholesterol between both groups. Also, There is a positive correlation between weight gain during pregnancy and neonatal cord blood levels of (Total cholesterol, TG, HDL-C, LDL-C and VLDL-C), There is a positive correlation between maternal blood levels of (total cholesterol, TG, LDL-C and VLDL-C) and their neonatal cord blood levels of (total cholesterol, TG, HDL-C, LDL-C and VLDL-C), There is a positive correlation between the maternal blood level of HDL-C and their neonatal cord blood levels of (total cholesterol and HDL-C).also, the cutoff values of cord blood (total Cholesterol, HDL-C, and LDL-C) below which RDS can be predicted are 80, 45.5 and 23.2 mg/dl respectively with a sensitivity of 83.3%, 86.7% and86.7% and with specificity of 95%, 80% and 70% respectively.


Conclusion: RDS is accompanied with lipid alteration in the infants and their mothers. The results of this study point to the importance of measuring maternal serum and cord blood lipid profile as a predictor for the occurrence of RDS.

Keywords:
  • cord serum, hyaline membrane disease, respiratory distress syndrome, preterm infants.

How to Cite

Mostafa Sallam, N. R. ., Ali Mohamed, S. E.-S. ., Abdulrahman Seliem, L. H. ., Mohamed Soliman, H. S. ., Abdelrahman Asker, M. F. ., & Eladel Ibrahim Abouelkhir, I. M. . (2024). Studies of Lipid Profiles Among Infants with Respiratory Distress Syndrome. Clinical Medicine And Health Research Journal, 4(6), 1024–1030. https://doi.org/10.18535/cmhrj.v4i6.409

Download Citation

References

  • Kim SY (2010): Neonatal respiratory distress: recent progress in understanding pathogenesis and treatment outcomes. Korean Journal of Pediatrics; (53):1-6.
  • Rodriguez RJ (2003): Management of respiratory distress syndrome: an update. Respir Care; 48(3): 279-86.
  • Mantan S and Arulkumaran S (2006): Neonatal RDS. Lancet; 367: 1878-9.
  • Keszler M and Abubakar KM (2012): The Respiratory System. In: Textbook of Clinical Pediatrics. 2nd ed. Elzouki AY, Harfi HA, Nazer HM, Stapleton FB, William OH and Whitley RJ (eds). 15: 195-215.
  • Mathai SS, Raju CU and Kanitkar CM (2007): Management of Respiratory Distress in the Newborn. Medical Journal Armed Forces India; 63: 269-272.
  • Pamela CC, Richard AH and Denise RF (2008): Biochemistry 4th edition. Lippincortt’s Illustrated reviews. Wolter’s Kruwer’s. USA. 178 - 179.
  • Marttila R, Haataja R, Guttentag S and Hallman M (2003): Surfactant Protein A and B Genetic Variants in Respiratory Distress Syndrome in Singletons and Twins. Am J Respir Crit Care Med; 168:1216–1222.
  • Hermansen CL and Lorah KN (2007): Respiratory distress in the newborn. American Family Physician; 76:987-94.
  • Herrera E (2002): Implications of dietary fatty acids during pregnancy on placental, fetal and postnatal development. Placenta; 23(A): S9–S19.
  • Madsen EM, Lindegaard MLS, Andersen CB, Damm PL and Nielsen LB (2004): Human placenta secretes apolipoprotein B-100-containing lipoproteins. J Biol Chem; 279: 55271– 6.
  • Chapman C, Morgan LM and Murphy MC (2000): Maternal and early dietary fatty acid intake: Changes Lipid Metabolism and enzymes in adult rats. J Nutr; 130(2):146-151.
  • Teslova OA, HiromaT, I Baranovskaya EI and NakamuraT (2012): Evaluation of factors influencing stable microbubble test results in preterm neonates at 30–33 gestational weeks. Research and Reports in Neonatology; 2: 5-10.
  • Butte NF, Ellis KJ, Wong WW, Hopkinson JM and Smith EO (2003): Composition of gestational weight gains impacts maternal fat retention and infant birth weight. Am J Obstet Gynecol; 189: 1423-1432.
  • Sollid CP, Wisborg K, Hjort J and Secher NJ (2004): Eating disorder that was diagnosed before pregnancy and pregnancy outcome. American Journal of Obstetrics and Gynecology; 190: 206-210.
  • Gunes T, koklu E and Ozturk MA (2007): Maternal and cord serum lipid profiles of preterm infants with respiratory distress syndrome. Journal of perinatology; 27:415-421.
  • Hansen AK, Wisborg K, Uldbjerg N and Henriksen TB (2008): Risk of respiratory morbidity in term infants delivered by elective caesarean section: Cohort study. BMJ; 336(7635): 85-7.
  • Kolås T, Saugstad OD, Daltveit AK, Nilsen ST and Øian P (2006): Planned cesarean versus planned vaginal delivery at term: comparison of newborn infant outcomes. Am J Obstet Gynecol; 195(6): 1538-43.
  • Descamps OS, Bruniaux M, Guilmot PF, Tonglet R and Heller FR (2004): Lipoprotein concentrations in newborns are associated with allelic variations in their mothers. Atherosclerosis; 172: 287-298.
  • Rodie VA, Caslake MJ, Stewart F, Sattar N, Ramsay JE, Greer IA and Freeman D (2004): Fetal cord plasma lipoprotein status in uncomplicated human pregnancies and in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. Atherosclerosis; 176: 181-187.
  • Saleh J, Al-Riyami HD, Chaudhary TA and Cianflone K (2008): Cord Blood ASP Is Predicted by Maternal Lipids and Correlates with Fetal Birth Weight. Obesity; 16: 1193-1198
  • Kelishadi R, Badiee Z and Adeli K (2007): Cord blood lipid profile and associated factors: baseline data of a birth cohort study. Paediatric and Perinatal Epidemiology; 21: 518-524.
  • Kharb S, Kaur A and Nanda S (2010): Comparison of cord blood atherogenic index in males and females. Iranian Cardiovascular Research Journal; 4(1):35-38.
  • Aasvee K, Kurvinen E, Jordania R, Jauhiainen M and Sundvall J (2004): Lipoprotein parameters in relation to other risk factors of atherosclerosis in adults and newborns: Tallinn Young Family Study. Scand J Clin Lab Invest; 64:245-253.
  • Bansal N, Cruickshank JK, McElduff P and Durrington PN (2005): Cord blood lipoproteins and prenatal influences. Curr Opin Lipidol; 16:400-408.
  • Parker CR, Atkinson MW, Owen J and Andrews WW (2006): Dynamics of the fetal adrenal, cholesterol, and apolipoprotein B responses to antenatal betamethasone therapy. Am J Obest Gynecol; 174: 562-5.
  • Lane DM, McConathy WJ, McCaffree MA and Hall M (2002): Cord serum lipid and apolipoprotein levels in preterm infants with the neonatal respiratory distress syndrome. J Matern Fetal neonatal Med; (11): 118-25.
  • Huxley R, Owen CG, Whincup PH, Cook DG, Colman S and Collins R (2004): Birth weight and subsequent cholesterol levels: exploration of the ‘fetal origins’ hypothesis. JAMA; 292: 2755-2764.
  • Jain R, Tripathi VN, Singh RD and Pandey K (2011): Lipid Profile and Apolipoproteins in Neonates in relation to Birth Weight and Gestational Maturity. Journal of Pediatric Sciences; 3(2): e80
  • Badiee Z and Kelishadi R (2008): Lipoprotein and apolipoprotein levels in Iranian newborns. Paediatr Cardiol; 29 (3):574-79.
  • Kaser S, Ebenbichler CF, Wolf HJ, Sandhofer A, Stanzl U, Ritsch A and Patsch JR (2001): Lipoprotein profile and cholesteryl esterase transfer protein in neonates. Metabolism; 50:723-728.
  • Burke KT, Colvin PL, Myatt L, Graf GA, Schroeder F and Woollett LA (2009): Transport of maternal cholesterol to the fetus is affected by maternal plasma cholesterol concentrations in the Golden Syrian hamster. J Lipid Res; 50: 1146-55.
  • Yoshida S and Wada Y (2005): Transfer of maternal cholesterol to embryo and fetus in pregnant mice. J Lipid Res; 46: 2168-74.
  • Herrera E, Amusquivar E, Lopez-Soldado I and Ortega-senovilla H (2006): Maternal lipid metabolism and placental lipid transfer. Horm Res; 65 (3): 59- 64.
  • Cetin I, Alvino G and Cardellicchio M (2009): Long chain fatty acids and dietary fats in fetal nutrition. J Physiol; 587(14): 3441-3451.
  • Herrera E and Ortega-senovilla H (2010): Maternal lipid metabolism during normal pregnancy and its implications to fetal development. Clin Lipidol; 5(6): 899-911.
    • Article Viewed: 0 Total Download

    ##plugins.themes.ojsPlusA.frontend.article.downloadstatastics##

    Cover Image

    Information